Skip to main content

Emergent BioSolutions Inc.

EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001367644

No open-market purchases or sales by Emergent BioSolutions Inc. insiders were filed in the last 90 days; 194 institutions reported holding it in 13F filings for Q2 2026, worth $373.6M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Emergent BioSolutions Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of EBS: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders2546233−15
Shares41.8M225.6K40.8M−795.2K (−1.9%)
Value$1.72B$9.26M$1.28B−$428.2M (−25.1%)

6 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Emergent BioSolutions Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to EBS in Q2 2022
InstitutionSharesValue% of portfolio
Marshall Wace, LLP448,533$13.9M0.03%
Bridgeway Capital Management, LLC253,000$7.85M0.18%
ExodusPoint Capital Management, LP33,549$1.04M0.01%
Sumitomo Mitsui Trust Holdings, Inc.19,539$606.0K0.00%
Caxton Associates LP16,719$519.0K0.06%
Arrowstreet Capital, Limited Partnership15,945$495.0K0.00%
Mirae Asset Global Investments Co., Ltd.15,628$485.0K0.00%
Quantedge Capital Pte Ltd14,100$438.0K0.09%
Walleye Capital LLC13,773$428.0K0.01%
Advisors Asset Management, Inc.6,725$209.0K0.00%
KBC Group NV4,614$143.0K0.00%
Simplex Trading, LLC3,193$99.0K0.00%
Islay Capital Management, LLC2,942$91.0K0.09%
EverSource Wealth Advisors, LLC189$6.00K0.00%
First Horizon Advisors, Inc.106$3.00K0.00%
Wagner Wealth Management, LLC100$3.00K0.00%
TD Waterhouse Canada Inc.65$2.67K0.00%
Lindbrook Capital, LLC45$1.00K0.00%
Massmutual Trust Co FSB15$00.00%
Bell Investment Advisors, Inc15$00.00%
CoreCap Advisors, LLC9$00.00%
Steward Financial Group LLC26$00.00%

Sold out (37)

Institutions that held Emergent BioSolutions Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (6)

Institutions that held Emergent BioSolutions Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EBS in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC143,222$5.88M
Susquehanna Fundamental Investments, LLC26,941$1.11M
Virginia Retirement Systems Et Al22,100$907.0K
Amalgamated Financial Corp.21,600$887.0K
Teachers Retirement System of the State of Kentucky11,700$480.0K
SJS Investment Consulting Inc.2$0